An interventional study of Intra-articular steroid injection in Breast Neoplasm, Shoulder Capsulitis and Range of Motion, sponsored by Yeungnam University Hospital. Completed at 1 site in Korea, Republic of. Open to female participants. Per ClinicalTrials.gov, last updated 2022-01-10.
Sponsored by Yeungnam University Hospital · Not applicable, Interventional, and Treatment
The prevalence of shoulder joint disease is high in breast cancer patients. The cause of adhesive capsulitis is not clearly identified. However, the following are known as relevant factors that are the restriction of the use of the arm after surgery, inflammation due to autoimmune action, radiation therapy, and adhesion of the surgical site. The purpose of this study is to compare and analyze the effect of intrathecal steroid injection in breast cancer survivors with adhesive capsulitis.
14,825 studies on the registry are indexed under Breast Neoplasms; 3,319 are open to participants now.
This study's enrollment of 28 is below the median of 72 across 10,896 interventional studies indexed under Breast Neoplasms.
Browse Breast Neoplasms studies →Yeungnam University Hospital is the lead sponsor of 8 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Intra-articular steroid injection
Procedure: Intra-articular steroid injection
Ultrasound-guided Gleno-humeral joint steroid (Triamcinolone 40mg with 0.5% lidocaine ) injection
Range of motion of shoulder joint
A goniometer is an instrument which measures the available range of motion at a joint.Flexion, Extension,Adduction,Abduction, Internal Rotation,External rotation
Time frame: Change from baseline at 3 months
Change in score on Shoulder Pain and Disability Index (SPADI)
SPADI is a scale consisting of 0-10; 0 being the best and 10 being the worse pain ever; higher scores mean a worse outcome.
Time frame: Change from baseline at 3 months
Axillary recess capsule thickness
Ultrasound measurements of axillary recess capsule thickness in unilateral frozen shoulder
Time frame: Change from baseline at 3 months
Plan to share: No
No publications or documents are linked to this record.
Ran from Oct 2020 to primary completion in Dec 2021, 14 months.
Of 2,661 non-industry interventional studies with no phase under Breast Neoplasms, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 66. This study's 14 months is below that.
Counting every sponsor, half of 2,771 studies reached it within 33 months; a quarter within 15 and three quarters within 66.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Yeungnam University Hospital